Lifevantage Director Buys $5.3k in Stock via 10b5-1 Plan
Lifevantage Corp
Subscribe to track LFVN
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Lifevantage Director Buys $5.3k in Stock via 10b5-1 Plan
Company: Lifevantage Corp (LFVN) Form: 4 | Filed: 2025-12-17 Significance: Low
Insider: Lewis Darwin Title: null | Relationship: Director
Transaction: • Type: Buy • Shares: 805 • Price: $6.54 • Value: $5,265 • Owned After: 131,553
Key Insight: This is a minor, pre-scheduled purchase under a Rule 10b5-1 plan, representing a negligible 0.007% of the company's market cap. Such trades typically carry little to no new informational value.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: Lifevantage Corp (LFVN)
Executive Summary
- Trading Significance: Low
- Key Takeaway: A director made a small, pre-planned purchase of common stock, representing an insignificant fraction of the company's market capitalization.
- Market Impact: The transaction is too small to have any meaningful impact on the stock.
Company Information
| Field | Value |
|---|---|
| Company | Lifevantage Corp |
| Ticker Symbol | LFVN |
| CIK | 0000849146 |
| Industry | Pharmaceutical Preparations |
Insider Information
| Field | Value |
|---|---|
| Name | Lewis Darwin |
| CIK | 0001698767 |
| Title/Position | null |
| Relationship | Director |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-12-15 |
| Transaction Code | P (Open market or private purchase) |
| Security Type | Common Stock |
| Shares Involved | 805 |
| Price Per Share | $6.5399 |
| Total Value | $5,264.62 |
| Shares Owned After | 131,553 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $5,264.62 |
| % of Market Cap | 0.007% |
| Shares Transacted | 805 |
| % of Shares Outstanding | 0.006% |
| Post-Transaction Ownership | 131,553 shares (1.04% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: For a company with an $80 million market cap, this ~$5,300 transaction is de minimis.
- Ownership Concentration: The purchase slightly increases the director's stake to just over 1% of total shares outstanding. While the overall holding is notable, this specific transaction is not a significant addition.
- Transaction Significance: The transaction's value is less than 0.1% of the market cap and the shares involved are less than 0.1% of shares outstanding, placing it firmly in the 'Low' significance category.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The trade is extremely small and was executed under a pre-scheduled Rule 10b5-1 plan, indicating it was not based on any immediate, non-public information.
Volume & Sentiment
- Expected Volume Impact: None. The transaction size is negligible compared to typical daily trading volume.
- Sentiment Indicator: Neutral. Pre-planned, small-value purchases do not typically influence market sentiment.
Additional Context
Transaction Notes
- Special Circumstances: The filing explicitly states the purchase was made pursuant to a Rule 10b5-1 trading plan adopted on February 10, 2025. This removes any implication of the trade being timed based on new information.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
